Merck & Co. (MRK)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
$0.15 (-0.14%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Merck & Co. (MRK)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Key Insights

Critical company metrics and information
  • Share Price

    $103.09
  • Market Cap

    $260.78 Billion
  • Total Outstanding Shares

    2.53 Billion Shares
  • Total Employees

    72,000
  • Dividend

    $0.81 Per Share Quarterly
  • IPO Date

    April 20, 1949
  • SIC Description

    Pharmaceutical Preparations
  • Homepage

    https://www.merck.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Exchange Gains/Losses$260.00 Million
Net Cash Flow, Continuing$5.76 Billion
Net Cash Flow From Investing Activities$-6.24 Billion
Net Cash Flow From Financing Activities, Continuing$-6.27 Billion
Net Cash Flow$6.02 Billion
Net Cash Flow From Investing Activities, Continuing$-6.24 Billion
Net Cash Flow From Operating Activities$18.26 Billion
Net Cash Flow From Operating Activities, Continuing$18.26 Billion
Net Cash Flow From Financing Activities$-6.27 Billion

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Cost Of Revenue$15.28 Billion
Basic Average Shares$2.53 Billion
Revenues$63.17 Billion
Income Tax Expense/Benefit$1.56 Billion
Other Operating Expenses$440.00 Million
Net Income/Loss Attributable To Parent$12.15 Billion
Operating Income/Loss$13.72 Billion
Net Income/Loss Available To Common Stockholders, Basic$12.15 Billion
Benefits Costs and Expenses$49.45 Billion
Income Tax Expense/Benefit, Deferred$-1.56 Billion
Research and Development$22.98 Billion
Costs And Expenses$49.45 Billion
Selling, General, and Administrative Expenses$10.76 Billion
Net Income/Loss Attributable To Noncontrolling Interest$15.00 Million
Net Income/Loss$12.16 Billion
Preferred Stock Dividends And Other Adjustments$0.00
Gross Profit$47.90 Billion
Diluted Earnings Per Share$4.78
Diluted Average Shares$2.54 Billion
Operating Expenses$34.18 Billion
Income/Loss From Continuing Operations Before Tax$13.72 Billion
Income/Loss From Continuing Operations After Tax$12.16 Billion
Basic Earnings Per Share$4.79
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Other Current Assets$34.12 Billion
Equity Attributable To Parent$44.50 Billion
Other Current Liabilities$26.00 Billion
Inventory$6.24 Billion
Current Assets$40.36 Billion
Equity Attributable To Noncontrolling Interest$58.00 Million
Liabilities$72.97 Billion
Noncurrent Assets$77.17 Billion
Current Liabilities$29.59 Billion
Other Non-current Assets$36.72 Billion
Accounts Payable$3.59 Billion
Noncurrent Liabilities$43.39 Billion
Fixed Assets$23.45 Billion
Liabilities And Equity$117.53 Billion
Equity$44.56 Billion
Assets$117.53 Billion
Intangible Assets$17.01 Billion

Historical Dividends

Current dividend: $0.81 Per Share Quarterly
Announcement DatePayment DateRecord DateAmountFrequency
Nov 19, 2024Jan 8, 2025Dec 16, 2024$0.81Quarterly
Jul 23, 2024Oct 7, 2024Sep 16, 2024$0.77Quarterly
May 28, 2024Jul 8, 2024Jun 17, 2024$0.77Quarterly
Jan 23, 2024Apr 5, 2024Mar 15, 2024$0.77Quarterly
Nov 28, 2023Jan 8, 2024Dec 15, 2023$0.77Quarterly
Jul 25, 2023Oct 6, 2023Sep 15, 2023$0.73Quarterly
May 23, 2023Jul 10, 2023Jun 15, 2023$0.73Quarterly
Jan 24, 2023Apr 10, 2023Mar 15, 2023$0.73Quarterly
Nov 29, 2022Jan 9, 2023Dec 15, 2022$0.73Quarterly
Jul 26, 2022Oct 7, 2022Sep 15, 2022$0.69Quarterly
May 24, 2022Jul 8, 2022Jun 15, 2022$0.69Quarterly
Jan 25, 2022Apr 7, 2022Mar 15, 2022$0.69Quarterly
Nov 30, 2021Jan 7, 2022Dec 15, 2021$0.69Quarterly
Jul 27, 2021Oct 7, 2021Sep 15, 2021$0.65Quarterly
May 25, 2021Jul 7, 2021Jun 15, 2021$0.65Quarterly
Jan 26, 2021Apr 7, 2021Mar 15, 2021$0.65Quarterly
Nov 17, 2020Jan 8, 2021Dec 15, 2020$0.65Quarterly
Jul 28, 2020Oct 7, 2020Sep 15, 2020$0.61Quarterly
May 26, 2020Jul 7, 2020Jun 15, 2020$0.61Quarterly
Jan 28, 2020Apr 7, 2020Mar 16, 2020$0.61Quarterly
Nov 19, 2019Jan 8, 2020Dec 16, 2019$0.61Quarterly
Jul 23, 2019Oct 7, 2019Sep 16, 2019$0.55Quarterly
May 28, 2019Jul 8, 2019Jun 17, 2019$0.55Quarterly
Jan 29, 2019Apr 5, 2019Mar 15, 2019$0.55Quarterly
Oct 25, 2018Jan 8, 2019Dec 17, 2018$0.55Quarterly
Jul 24, 2018Oct 5, 2018Sep 17, 2018$0.48Quarterly
May 22, 2018Jul 9, 2018Jun 15, 2018$0.48Quarterly
Jan 23, 2018Apr 6, 2018Mar 15, 2018$0.48Quarterly
Nov 28, 2017Jan 8, 2018Dec 15, 2017$0.48Quarterly
Jul 25, 2017Oct 6, 2017Sep 15, 2017$0.47Quarterly
May 23, 2017Jul 10, 2017Jun 15, 2017$0.47Quarterly
Feb 28, 2017Apr 7, 2017Mar 15, 2017$0.47Quarterly
Nov 22, 2016Jan 9, 2017Dec 15, 2016$0.47Quarterly
Jul 26, 2016Oct 7, 2016Sep 15, 2016$0.46Quarterly
May 24, 2016Jul 8, 2016Jun 15, 2016$0.46Quarterly
Feb 23, 2016Apr 7, 2016Mar 15, 2016$0.46Quarterly
Nov 24, 2015Jan 8, 2016Dec 15, 2015$0.46Quarterly
Jul 22, 2015Oct 7, 2015Sep 15, 2015$0.45Quarterly
May 26, 2015Jul 8, 2015Jun 15, 2015$0.45Quarterly
Feb 24, 2015Apr 8, 2015Mar 16, 2015$0.45Quarterly
Nov 25, 2014Jan 8, 2015Dec 15, 2014$0.45Quarterly
Jul 23, 2014Oct 7, 2014Sep 15, 2014$0.44Quarterly
May 27, 2014Jul 8, 2014Jun 16, 2014$0.44Quarterly
Feb 25, 2014Apr 7, 2014Mar 17, 2014$0.44Quarterly
Nov 26, 2013Jan 8, 2014Dec 16, 2013$0.44Quarterly
Jul 24, 2013Oct 7, 2013Sep 16, 2013$0.43Quarterly
May 28, 2013Jul 8, 2013Jun 17, 2013$0.43Quarterly
Feb 26, 2013Apr 5, 2013Mar 15, 2013$0.43Quarterly
Nov 27, 2012Jan 8, 2013Dec 17, 2012$0.43Quarterly

Related Companies

View additional S&P 500 companies similar to Merck & Co. (MRK)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.